Health
A target for potential cancer drugs may, in fact, worsen disease – EurekAlert
Researchers reveal a previously unrealized complexity in cancer development, one that raises concerns and caution about targeting…
In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyrosine phosphatase 2 or more briefly, Shp2.
Shp2 is a phosphotyrosine phosphatase; its…
Continue Reading
-
Noosa News17 hours agoHow Lily Steele-Park took her rapist to court and won
-
General23 hours agoRush to buy homes before rate cuts send prices soaring
-
Business22 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business19 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025